| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gastrointestinal Research Group and Departments of 1 Pediatrics, 3 Physiology and Biophysics, and 2 Medicine, Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada T2N 1N4
To determine whether treatment with a potent protease-resistant analog of human glucagon-like peptide 2 (GLP-2) might augment the adaptive response to massive intestinal resection, rats were divided into resected, which had 75% of the midjejunoileum removed, sham-resected, and nonsurgical groups. Within each group, animals were assigned to 21 days of treatment with the drug (0.1 µg/g of the GLP-2 analog in phosphate-buffered saline) or vehicle alone subcutaneously twice daily. Food intake; weight gain; jejunal and ileal diameters, total and mucosal wet weights per centimeter, crypt depths, and villus heights; mucosal sucrase activity, milligrams of protein per centimeter, and micrograms of DNA per centimeter; and D-xylose absorption were measured. There was a significant increase in diameter, total and mucosal wet weights per centimeter, crypt-villus height, sucrase activity, milligrams of protein per centimeter and micrograms of DNA per centimeter in both the jejunum and ileum in response to resection and a significant additive response to the GLP-2 analog in the jejunum but not in the ileum. The ratio of milligrams of protein per centimeter to micrograms of DNA per centimeter of mucosa was not different among groups, consistent with hyperplasia. D-Xylose absorption was significantly reduced in response to resection; however, the GLP-2 analog enhanced the absorptive capacity in control animals and restored the absorptive capacity in resected animals. Thus the GLP-2 analog induces mucosal hyperplasia and enhances the rate and magnitude of the proximal intestinal adaptive response to massive resection.
intestinal adaptation; short gut; glucagon-like peptide 2; growth factor
This article has been cited by other articles:
|
|
 |
|
  A. P. Garrison, C. M. Dekaney, D. C. von Allmen, P. K. Lund, S. J. Henning, and M. A. Helmrath Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G643 - G650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tian, L. Hao, P. Chandra, D. P. Jones, I. R. Willams, A. T. Gewirtz, and T. R. Ziegler Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G348 - G355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, S. G. Murali, J. J. Holst, and D. M. Ney Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1794 - R1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Helmrath, J. J. Fong, C. M. Dekaney, and S. J. Henning Rapid expansion of intestinal secretory lineages following a massive small bowel resection in mice Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G215 - G222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M Sinclair and D. J. Drucker Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential Physiology, October 1, 2005; 20(5): 357 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Martin, L. E. Wallace, B. Hartmann, J. J. Holst, L. Demchyshyn, K. Toney, and D. L. Sigalet Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G431 - G438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Iordache, L. Drozdowski, M. T. Clandinin, G. Wild, Z. Todd, and A. B. R. Thomson Treatment of suckling rats with GLP-2 plus dexamethasone increases the ileal uptake of fatty acids in later life Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G54 - G59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Martin, L. E. Wallace, and D. L. Sigalet Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G964 - G972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ramsanahie, M. S. Duxbury, T. C. Grikscheit, A. Perez, D. B. Rhoads, J. Gardner-Thorpe, J. Ogilvie, S. W. Ashley, J. P. Vacanti, and E. E. Whang Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1345 - G1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Dahly, Z. Guo, and D. M. Ney IGF-I augments resection-induced mucosal hyperplasia by altering enterocyte kinetics Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R800 - R808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Cameron, P.-C. Yang, and M. H. Perdue Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G905 - G912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Dahly, M. B. Gillingham, Z. Guo, S. G. Murali, D. W. Nelson, J. J. Holst, and D. M. Ney Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G670 - G682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Gillingham, E. M. Dahly, S. G. Murali, and D. M. Ney IGF-I treatment facilitates transition from parenteral to enteral nutrition in rats with short bowel syndrome Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R363 - R371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Drucker Gut adaptation and the glucagon-like peptides Gut, March 1, 2002; 50(3): 428 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Petersen, D. G. Burrin, and P. T. Sangild GLP-2 has differential effects on small intestine growth and function in fetal and neonatal pigs Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1986 - R1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Gillingham, K. R. Kritsch, S. G. Murali, P. K. Lund, and D. M. Ney Resection upregulates the IGF-I system of parenterally fed rats with jejunocolic anastomosis Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1158 - G1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ljungmann, B. Hartmann, P. Kissmeyer-Nielsen, A. Flyvbjerg, J. J. Holst, and S. Laurberg Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G779 - G785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-associated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor Cancer Res., January 1, 2001; 61(2): 687 - 693. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Secor, E. E. Whang, J. S. Lane, S. W. Ashley, and J. Diamond Luminal and systemic signals trigger intestinal adaptation in the juvenile python Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1177 - G1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Burrin, B. Stoll, R. Jiang, Y. Petersen, J. Elnif, R. K. Buddington, M. Schmidt, J. J. Holst, B. Hartmann, and P. T. Sangild GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1249 - G1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rubin, E. A. Swietlicki, H. Iordanov, C. Fritsch, and M. S. Levin Novel goblet cell gene related to IgGFcgamma BP is regulated in adapting gut after small bowel resection Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1003 - G1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P B Jeppesen, B Hartmann, J Thulesen, B S Hansen, J J Holst, S S Poulsen, and P B Mortensen Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon Gut, September 1, 2000; 47(3): 370 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M A Benjamin, D M McKay, P-C Yang, H Cameron, and M H Perdue Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse Gut, July 1, 2000; 47(1): 112 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kitchen, A. J. Fitzgerald, R. A. Goodlad, N. F. Barley, M. A. Ghatei, S. Legon, S. R. Bloom, A. Price, J. R. F. Walters, and A. Forbes Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G425 - G428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tavares, D. J. Drucker, and P. L. Brubaker Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E134 - E139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Thulesen, B Hartmann, C Nielsen, J J Holst, and S S Poulsen Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre Gut, November 1, 1999; 45(5): 672 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E937 - E947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Yusta, R. Somwar, F. Wang, D. Munroe, S. Grinstein, A. Klip, and D. J. Drucker Identification of Glucagon-like Peptide-2 (GLP-2)-activated Signaling Pathways in Baby Hamster Kidney Fibroblasts Expressing the Rat GLP-2 Receptor J. Biol. Chem., October 22, 1999; 274(43): 30459 - 30467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Yusta, R. P. Boushey, and D. J. Drucker The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway J. Biol. Chem., November 3, 2000; 275(45): 35345 - 35352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bjerknes and H. Cheng Modulation of specific intestinal epithelial progenitors by enteric neurons PNAS, October 23, 2001; 98(22): 12497 - 12502. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
